Active Funding Announcements and Notices for NICHD

NICHD publishes and participates in various Funding Opportunity Announcements (FOAs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active FOAs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how the information is sorted.

Number Exp. Date Activity Code(s) Title
PAR-21-319 December 12, 2023 R21 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
PAR-21-311 December 12, 2023 R01 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
PA-21-345 September 10, 2024 333 Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
NOT-NS-22-023 January 1, 2024 Notice of Intent to Publish a Funding Opportunity Announcement for NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25 Clinical Trial Not Allowed)
NOT-HD-21-043 January 1, 2024 Notice of Intent to Publish a Funding Opportunity Announcement for Adolescent Medicine Trials Network for HIV/AIDS Intervention (ATN) Scientific Leadership Center (UM2 Clinical Trial Required), and Operations and Collaborations Center (UM1 Clinical Trial)
NOT-MH-21-310 January 1, 2024 The BRAIN Initiative Plan for Enhancing Diverse Perspectives (PEDP)
PAR-21-297 December 10, 2023 R43/R44 Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed)
PAR-21-298 December 10, 2023 R41/R42 Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed)
RFA-HG-21-037 November 2, 2021 UM1 Limited Competition: Knockout Mouse Phenotyping Project Data Coordination Center and Database (UM1 Clinical Trial Not Allowed)
RFA-HG-21-036 November 2, 2021 UM1 Limited Competition: Knockout Mouse Production and Phenotyping Project (UM1) Clinical Trial Not Allowed
NOT-NS-22-012 September 30, 2024 333 Notice of Special Interest to Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
RFA-HD-22-005 December 1, 2021 P20 Learning Disabilities Innovation Hubs (P20 Clinical Trial Optional)
RFA-HD-22-009 November 30, 2021 P01 Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional)
NOT-NS-21-068 November 6, 2021 333 HEAL Initiative: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements to Support Strategies to Advance the Study of Chronic Overlapping Pain Conditions (COPCs)
RFA-HD-22-008 November 10, 2021 P50 Autism Centers of Excellence: Centers (P50 Clinical Trial Optional)
RFA-HD-22-007 November 10, 2021 R01 Autism Centers of Excellence: Networks (R01 Clinical Trial Optional)
NOT-MH-21-330 September 8, 2024 R01,UG3/UH3 Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations
PAR-21-282 June 21, 2024 U44 Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)
PAR-21-315 June 21, 2024 UG3/UH3 Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
PAR-21-314 October 21, 2021 U54 Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed)
top of pageBACK TO TOP